Physician profile
Prince Sethi
NPI 1659727014
$6,605.82
in general payments reported to CMS, 2019-2025
12 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $129 · 2021: $522 · 2022: $3,101 · 2023: $1,826 · 2024: $537 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964 · Travel and Lodging: $696 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,963.63 |
| Travel and Lodging | $696.30 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,729.90 | 2019-2023 | Watchman Flx |
| Medtronic, INC. | $1,165.12 | 2021-2025 | Corevalve Evolut R, Micra |
| Edwards Lifesciences Corporation | $961.38 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Philips North America LLC | $403.40 | 2023-2024 | (Br4) Coronary Undivided, (6391) Nexcimer, (Cj8) Igt Devices Systems Undivided |
| Biotronik INC. | $311.91 | 2023-2024 | Orsiro Mission, Nhancer Rx |
| Abbott Laboratories | $267.23 | 2021-2024 | Diamondback Coronary, Tacticath Ablation Catheter, Sensor Enabled, Viewmate |
| Shockwave Medical, INC | $238.01 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $235.29 | 2025 | Trapliner, Orsiro Mission |
| Medtronic Vascular, INC. | $129.10 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.88 | 2023-2024 | Lifevest |
| Abiomed | $38.77 | 2024 | Impella |
| Amgen INC. | $14.89 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prince Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.